Studies about multiple myeloma illustrated that regarded as an oncogene, FGFR3 promoted occurrence and development of tumors [36] and was escalated in several other types of tumor, indicating its negative effects in cancer pathogenesis [3–5]. The gene discussed is FGFR3; the disease is neoplasm.